La cadena de opciones muestra datos clave de las opciones de acciones de Allarity Therapeutics a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Allarity Therapeutics..

Allarity Therapeutics (NASDAQ:ALLR) Bolsa, Cadena de Opciones

Allarity Therapeutics

Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improves clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.

Tesla Rival XPeng Eyes $13.8 Billion Investment In Humanoid Robots, Says Chinese State Media

Equities

Market Summary

News

Pre-Market Outlook

Markets

Trading Ideas

ALLR

NCNO

SPWH

ULBI

XPEV

Aquí tienes cinco acciones estadounidenses que podrían llamar la atención de los inversores este martes: ULBI, XPEV, NCNO, ALLR y SPWH.

5 acciones en el foco este martes: ULBI, XPEV, NCNO, ALLR y SPWH

Allarity Therapeutics, Inc. - Common stock

Allarity Therapeutics Inc

Allreal Holding Ltd

RBC Capital analyst Josh Wolfson maintains Anglogold Ashanti (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AU#NYSE">AU</a>) with a Outperform and raises the price target from $39 to $41.

Price Target

Analyst Ratings

RBC Capital Maintains Outperform on Anglogold Ashanti, Raises Price Target to $41

Barclays analyst Manav Patnaik maintains Rollins (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ROL#NYSE">ROL</a>) with a Equal-Weight and raises the price target from $50 to $55.

Barclays Maintains Equal-Weight on Rollins, Raises Price Target to $55

American Airlines Group's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAL#NYSE">AAL</a>) short percent of float has fallen 3.34% since its last report. The company recently reported that it has 58.69 million shares sold short, which is 10.13% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.0 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>American Airlines Group Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743774337_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for American Airlines Group has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing American Airlines Group's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, American Airlines Group's peer group average for short interest as a percentage of float is 9.45%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

How Do Investors Really Feel About American Airlines Group?

NVIDIA's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NYSE">NVDA</a>) short percent of float has risen 6.8% since its last report. The company recently reported that it has 258.07 million shares sold short, which is 1.1% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.0 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>NVIDIA Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743774331_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for NVIDIA has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing NVIDIA's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, NVIDIA's peer group average for short interest as a percentage of float is 5.70%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

NVDA

Peering Into NVIDIA's Recent Short Interest

RB Global's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBA#NYSE">RBA</a>) short percent of float has risen 13.6% since its last report. The company recently reported that it has 4.04 million shares sold short, which is 2.84% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.49 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>RB Global Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743774326_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for RB Global has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing RB Global's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, RB Global's peer group average for short interest as a percentage of float is 5.57%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Is the Market Bullish or Bearish on RB Global?

Barclays analyst Manav Patnaik maintains Vestis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VSTS#NYSE">VSTS</a>) with a Underweight and lowers the price target from $13 to $10.

VSTS

Barclays Maintains Underweight on Vestis, Lowers Price Target to $10

Renovaro Biosciences Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RENB#NASDAQ">RENB</a>), a TechBio leader focused on next-generation diagnostics, drug discovery, and genetically enhanced cancer therapies, today provided an update regarding its <a href="https://www.globenewswire.com/Tracker?data=ZSoeVpBru0Jx4CD_1RKHy2Q7QAHZTPOcJfgpOKgWbC63uziRSIzUvsHQocHVMfBtpz5f_A1OqEOVgyAUJecQeoDTX1zgksMauVZ1Tzc7-aXfNI5fx_Klb_byyZH6V4ivnGljkmcWT9IjbkWdYbv8j6Svz72U2-ItJCti0BUpSY0qLctk5NFOugR3uBRdxTnC2oSy0rbL-eeOrRkgybtm8aBmJ2rQF4ZMo7rTsQWgLQON2C0eq9ZD8AH1BXF4CUauCRMsnF3zgTb3jxbvAFNVFXFt7bdzLNjPH63DnI5ysYc=">Definitive Agreement</a> with Predictive Oncology Predictive Oncology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POAI#NASDAQ">POAI</a>) to initiate the <a href="https://www.globenewswire.com/Tracker?data=MWAHihxZXioTSRkb9OHzZ513CIRLqNu7WuL4Si4AZqf6U7sigKgzG3km2_lvBq1ki4XRfVq2fBGOj13OCubI0yZ50chBrnzaNiCBuigZxwbXUEt02MqOf7tsFTdUdHFMQ0TcJue2fCTgh9PMgTYQ60gJvwGUIyX5q2_Kua7pwbolFunjrTBPd3_eTXw_0eF6jw0Wo2xfMjTrn31Vq6c7TkAbymxyJCmJ_5MRz-Y1XW4=">previously announced</a> integration of AI/ML platform technologies, core laboratory capabilities and business development efforts in Europe and the United States.
Renovaro entered into a binding agreement merger agreement with Predictive Oncology, Inc. ("POI") dated January 1, 2025, and supplemented with the Extension Agreement dated February 28, 2025 (collectively, the "Binding Agreements"). On April 3, 2025, Renovaro received an email from POI terminating the merger transaction. Renovaro's position is that POI must comply with the binding obligations thereunder and enter into an exclusive License Agreement as required in each of the Binding Agreements. Renovaro notes that POI is in breach of the Binding Agreements and has caused substantial damage to Renovaro for which it will seek redress. Failure to enter into an exclusive License Agreement on the terms set forth in the Binding Agreement on or before April 10, 2025, will cause Renovaro to seek all its legal remedies to recover all its damages and/or seek additional remedies to fully redress the breaches.

Contracts

POAI

RENB

Renovaro Biosciences Responds To Predictive Oncology's Termination Of Merger Agreement, Asserting Breach Of Binding Contracts And Intent To Pursue Legal Remedies For Damages And Non-Compliance With Exclusive License Agreement

Macro Economic Events

Economics

General

Benzinga Market Summary China Imposes 34% Tariffs On US Goods, S&P Falls Over 3% On Tariff Tensions; US Dollar Rises, Oil Falls Amid Tariff Concerns And OPEC Production Increase

RBC Capital analyst Josh Wolfson maintains Agnico Eagle Mines (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AEM#NYSE">AEM</a>) with a Outperform and raises the price target from $110 to $115.

RBC Capital Maintains Outperform on Agnico Eagle Mines, Raises Price Target to $115

Barclays analyst Manav Patnaik maintains TransUnion (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRU#NYSE">TRU</a>) with a Equal-Weight and lowers the price target from $105 to $85.

Barclays Maintains Equal-Weight on TransUnion, Lowers Price Target to $85

RBC Capital analyst Michael Siperco maintains Eldorado Gold (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EGO#NYSE">EGO</a>) with a Outperform and raises the price target from $20 to $21.

RBC Capital Maintains Outperform on Eldorado Gold, Raises Price Target to $21

Barclays analyst Manav Patnaik maintains Moodys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCO#NYSE">MCO</a>) with a Overweight and lowers the price target from $570 to $520.

Barclays Maintains Overweight on Moodys, Lowers Price Target to $520

ICCT

iCoreConnect Shares Resume Trade

AREB

American Rebel Holdings Shares Resume Trade

Barclays analyst Manav Patnaik maintains MSCI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSCI#NYSE">MSCI</a>) with a Overweight and lowers the price target from $675 to $650.

MSCI

Barclays Maintains Overweight on MSCI, Lowers Price Target to $650

EHang Holdings Limited ("EHang" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EH#NASDAQ">EH</a>), the world's leading Urban Air Mobility ("UAM") technology platform company, stated today that recent tariff developments between China and the United States are not expected to have any material impact on the Company's operations.
Recent U.S. tariff adjustments on certain Chinese goods have triggered global market volatility, and EHang has experienced short-term share price fluctuations driven by market sentiment. In response, the Company hereby clarifies the following:
Recent tariff measures announced by both governments are not expected to have any material impact on EHang's operations. The Company does not currently export its autonomous aerial vehicles (AAVs) or related products to the U.S. market, nor does it rely on U.S.-origin components in its manufacturing processes. We do not use U.S.-restricted semiconductors, aerospace components, or other controlled technologies. Our supply chain remains secure and independent, ensuring no operational disruption due to trade policy changes.

Global

EHang Holdings Assures No Material Impact On Operations From Recent U.S.-China Tariff Adjustments, Clarifying No Exports To U.S. And Secure, Independent Supply Chain

Barclays analyst Manav Patnaik maintains Gartner (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IT#NYSE">IT</a>) with a Overweight and lowers the price target from $600 to $510.

Barclays Maintains Overweight on Gartner, Lowers Price Target to $510

iCoreConnect Shares Halted On Circuit Breaker To The Upside, Stock Now Up 37.8%

B of A Securities analyst Craig Siegenthaler maintains TPG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPG#NASDAQ">TPG</a>) with a Buy and lowers the price target from $72 to $68.

B of A Securities Maintains Buy on TPG, Lowers Price Target to $68

Movers

American Rebel Holdings Shares Halted On Circuit Breaker

Press Releases

Allarity Therapeutics Announces Dismissal of Securities Class Action Lawsuit

Allarity Therapeutics Announces Board Authorization of $5 Million Share Repurchase Program

Allarity Therapeutics Announces Phase 2 Trial of Stenoparib in Combination with Temozolomide for Recurrent Small Cell Lung Cancer Fully Funded by the US Veterans Administration

Allarity Therapeutics Announces Final Settlement with the U.S. Securities and Exchange Commission

Penny Stocks

ALLR Investors Have Opportunity to Join Allarity Therapeutics, Inc. Securities Fraud Investigation with the Schall Law Firm

Biotech

Allarity Therapeutics Announces Presentation of Phase 2 Clinical Data from Ongoing Trial in Advanced Ovarian Cancer Patients at the 2025 Annual Meeting for the Society of Gynecologic Oncology

Comments

Allarity Therapeutics

Allarity Therapeutics (ALLR) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL